HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3-hydroxypyridine chromophores are endogenous sensitizers of photooxidative stress in human skin cells.

Abstract
Photocarcinogenesis and photoaging are established consequences of chronic exposure of human skin to solar irradiation. Accumulating evidence supports a causative involvement of UVA irradiation in skin photo-damage. UVA photodamage has been attributed to photosensitization by endogenous skin chromophores leading to the formation of reactive oxygen species and organic free radicals as key mediators of cellular photooxidative stress. In this study, 3-hydroxypyridine derivatives contained in human skin have been identified as a novel class of potential endogenous photosensitizers. A structure-activity relationship study of skin cell photosensitization by endogenous pyridinium derivatives (pyridinoline, desmosine, pyridoxine, pyridoxamine, pyridoxal, pyridoxal-5'-phosphate) and various synthetic hydroxypyridine isomers identified 3-hydroxypyridine and N-alkyl-3-hydroxypyridinium cation as minimum phototoxic chromophores sufficient to effect skin cell sensitization toward UVB and UVA, respectively. Photosensitization of cultured human skin keratinocytes (HaCaT) and fibroblasts (CF3) by endogenous and synthetic 3-hydroxypyridine derivatives led to a dose-dependent inhibition of proliferation, cell cycle arrest in G2/M, and induction of apoptosis, all of which were reversible by thiol antioxidant intervention. Enhancement of UVA-induced intracellular peroxide formation and p38 mitogen-activated protein kinase-dependent stress signaling suggest a photooxidative mechanism of skin cell photosensitization by 3-hydroxypyridine derivatives. 3-hydroxypyridine derivatives were potent photosensitizers of macromolecular damage, effecting protein (RNase A) photocross-linking and peptide (melittin) photooxidation with incorporation of molecular oxygen. Based on these results, we conclude that 3-hydroxypyridine derivatives comprising a wide range of skin biomolecules, such as enzymatic collagen cross-links, B6 vitamers, and probably advanced glycation end products in chronologically aged skin constitute a novel class of UVA photosensitizers, capable of skin photooxidative damage.
AuthorsGeorg T Wondrak, Michael J Roberts, Myron K Jacobson, Elaine L Jacobson
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 29 Pg. 30009-20 (Jul 16 2004) ISSN: 0021-9258 [Print] United States
PMID15133022 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antioxidants
  • Cations
  • Peptides
  • Photosensitizing Agents
  • Pyridines
  • Pyridinium Compounds
  • Reactive Oxygen Species
  • Desmosine
  • 3-hydroxypyridine
  • Vitamin B 6
  • Hydrogen Peroxide
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Ribonuclease, Pancreatic
Topics
  • Antioxidants (pharmacology)
  • Apoptosis
  • Cations
  • Cell Cycle
  • Cell Division
  • Cell Line
  • Cells, Cultured
  • Desmosine (metabolism)
  • Dose-Response Relationship, Drug
  • Fibroblasts (metabolism)
  • Flow Cytometry
  • Humans
  • Hydrogen Peroxide (pharmacology)
  • Light
  • Mitogen-Activated Protein Kinases (metabolism)
  • Models, Chemical
  • Oxidative Stress
  • Peptides (chemistry)
  • Photosensitizing Agents (pharmacology)
  • Pyridines (pharmacology)
  • Pyridinium Compounds (chemistry)
  • Reactive Oxygen Species
  • Ribonuclease, Pancreatic (metabolism)
  • Skin (cytology, metabolism)
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Structure-Activity Relationship
  • Ultraviolet Rays
  • Vitamin B 6 (metabolism)
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: